Cambridge Cognition Holdings Plc (AIM:COG)
London · Delayed Price · Currency is GBP · Price in GBX 34.50
+0.50 (1.47%)
Sep 9, 2025, 1:45 PM GMT+1
AIM:COG Market Cap
AIM:COG has a market cap or net worth of 14.23 million as of September 9, 2025. Its market cap has decreased by -24.86% in one year.
Market Cap
14.23M
Enterprise Value
15.30M
Revenue
9.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.50
Market Cap Chart
Since April 18, 2013, AIM:COG's market cap has increased from 13.12M to 14.23M, an increase of 8.52%. That is a compound annual growth rate of 0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 14.23M | -8.83% |
| Dec 31, 2024 | 15.61M | -2.50% |
| Dec 29, 2023 | 16.01M | -54.81% |
| Dec 30, 2022 | 35.44M | -9.78% |
| Dec 31, 2021 | 39.28M | 88.84% |
| Dec 31, 2020 | 20.80M | 208.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.48B |
| GSK plc | 59.44B |
| Haleon | 32.74B |
| Smith & Nephew | 12.30B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.81B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.76B |